AstraZeneca Annual Report and 128 Form 20-F Information 2005 NOTES TO THE FINANCIAL STATEMENTS CONTINUED 28 SHARE CAPITAL OF PARENT COMPANY Authorised Allotted, called-up and fully paid 2005 2005 2004 2003 $m $m $m $m Issued Ordinary Shares $0.25 each 395 395 411 423 Unissued Ordinary Shares $0.25 each 205 Redeemable Preference Shares 1 each 50,000 600 395 411 423 The Redeemable Preference Shares carry limited class voting rights and no dividend rights.
This class of shares is capable of redemption at par at the option of the Company on the giving of seven days written notice to the registered holder of the shares.
The movements in share capital during the year can be summarised as follows: No.
of shares million $m At 1 January 2005 1,645 411 Issues of shares 41 Re-purchase of shares 68 17 At 31 December 2005 1,581 395 Share re-purchase During the year the Company re-purchased, and subsequently cancelled, 67,650,000 Ordinary Shares at an average price of 2445 pence per share.
The total consideration, including expenses, was $3,001m.
The excess of the consideration over the nominal value has been charged against retained earnings.
Share schemes A total of 3,500,109 Ordinary Shares were issued during the year in respect of share schemes.
Details of movements in the number of Ordinary Shares under option are shown in Note 24: details of options granted to Directors are shown in the Directors Remuneration Report.
Shares held by subsidiaries No shares in the Company are held by subsidiaries in any year.
